Jianxin Bao

Company: Gateway Biotechnology Inc.

Job title: Chief Executive Officer

Seminars:

Developing Disease-Specific Biomarkers to Sub-Type Acquired Hearing Disorders for Improved Therapeutic Interventions 2:30 pm

Identifying specific cochlear damage (i.e. noise-induced and age-related) and the varying scale of synapse damage in sensorineural hearing loss Establishing unified and objective categorization of hearing loss subtypes based on damage to specific cell types, beyond observable changes Understanding the lack of translational data following preclinical screening for different noise intensity, noise types and varying…Read more

day: Conference Day 2